GHK-Cu

GHK-Cu (100mg) — Research Peptide

GHK-Cu at 100mg per vial represents the highest-concentration format available, suited to research protocols requiring large batch volumes, high-concentration stock solution preparation, or extended multi-arm experimental designs. GHK-Cu is a naturally occurring copper-binding tripeptide with one of the broadest published research bases of any skin biology peptide, spanning collagen synthesis, wound healing, anti-inflammatory signalling, and transcriptome-level gene regulation.

Research Applications for High-Dose Format

The 100mg format is particularly suited to:

• In vitro cell culture studies requiring large volumes of reconstituted peptide solution
• Multi-concentration dose-response experiments from a single batch
• Extended in vivo wound healing protocols requiring consistent supply over 12+ weeks
• Tissue engineering research requiring high-concentration matrix incorporation

Key Research Findings

GHK-Cu’s published research base includes documented activity in: fibroblast collagen I and III synthesis (TGF-β1 pathway); glycosaminoglycan and decorin production in skin explant models; MMP-1 downregulation and TIMP-1/2 upregulation preserving ECM integrity; anti-inflammatory cytokine suppression (TNF-α, IL-6, IL-8); and gene expression modulation across pathways involved in tissue remodelling, DNA repair, and stem cell maintenance.

Product Specifications

• Compound: GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex)
• Dose: 100mg per vial
• Format: Lyophilised powder, bulk box of 10 vials
• Purity: ≥98% Janoshik HPLC verified
• Storage: -20°C. 24-month stability.

For laboratory research use only. Not for human cosmetic or therapeutic use.